Evidence map›Paper›PMID 29623665›Full record

ArticleObesity surgery2018

Laparoscopic Gastric Bypass with Fundectomy and Gastric Remnant Exploration (LRYGBfse): Results at 5-Year Follow-up.

Giovanni Lesti, Alberto Aiolfi, Enrico Mozzi, Fabrizio Altorio, Ezio Lattuada, Francesco Lesti, Gianluca Bonitta, Marco Antonio Zappa

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giovanni LestiDepartment of General Surgery, Fondazione Salus Clinica Di Lorenzo, Via Vittorio Veneto n 37, Avezzano, L'Aquila, Italy.
Alberto AiolfiDepartment of Biomedical Science for Health, Division of General and Emergency Surgery, University of Milan, Milan, Milan, Italy. alberto.aiolfi86@gmail.com.ORCID 0000-0002-7764-6075
Enrico MozziDivision of General Surgery, Istituto Auxologico Italiano - IRCCS, Milan, Milan, Italy.
Fabrizio AltorioDepartment of General Surgery, Fondazione Salus Clinica Di Lorenzo, Via Vittorio Veneto n 37, Avezzano, L'Aquila, Italy.
Ezio LattuadaDepartment of General Surgery, Istituto Clinico Humanitas San Pio X, Humanitas University, Milan, Milan, Italy.
Francesco LestiDepartment of General Surgery, Fondazione Salus Clinica Di Lorenzo, Via Vittorio Veneto n 37, Avezzano, L'Aquila, Italy.
Gianluca BonittaDepartment of Biomedical Science for Health, Division of General and Emergency Surgery, University of Milan, Milan, Milan, Italy.
Marco Antonio ZappaDepartment of General and Emergency Surgery, Ospedale Fatebenefratelli Sacra Famiglia, University of Milan, Erba, Como, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe laparoscopic Roux-en-Y gastric bypass (LRYGB) is the gold standard treatment for morbid obesity. After LRYGB, the endoscopic access to the gastric remnant and pancreaticobiliary system is challenging. The laparoscopic gastric bypass with fundectomy and exploration of the gastric remnant (LRYGBfse) was introduced in an attempt to overcome this limitation. The purpose of this study was to analyze the medium-term outcomes and safety of LRYGBfse.

methodsObservational prospective single-arm multicenter cohort study. Patients with BMI > 35 kg/m

resultsAmong 653 enrolled patients, 229 completed the 5-year follow-up. Preoperative median body weight (kg) and BMI (kg/m

conclusionsThe LRYGBfse seems safe and effective with durable results at 5-year follow-up. Endoscopic exploration of the gastric remnant is an additional valuable tool.

Indexed as

GastrectomyGastric BypassLaparoscopyFollow-Up StudiesGastric StumpHumansObesity, MorbidBariatric surgeryGastric bypassGastric fundectomyGhrelinOutcomes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.